Full Description
Based on interviews with dedicated biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.
Contents
INTRODUCTION Development of the Private Equity and Venture Capital Market Development of the Biotech Industry METHODOLOGY Formulating the Research Goal Conducting the Study Evaluating the Results DATA ANALYSIS AND INTERPRETATION OF RESULTS Description of Interview Partners Major Characteristics of an Entrepreneur Major Characteristics of a Venture Capitalist The Most Important Partnering Criteria Financing Models Biotech Research Areas Alliances and Funding in the Early Stage Alliances and Funding in the Late Stage Exit Routes Primary Causes of Failure Best-practice Countries for Funding Biotech Start-ups Striking Differences between the US and European Venture Capital Markets BIOTECH CASE STUDIES AUSTRIANOVA Biomanufacturing AG AVIR Green Hills Biotechnology AG EUCODIS GmbH Intercell AG onepharm Research & Development GmbH SUMMARY AND CONCLUSIONS The Challenge: When Science Meets Business Checklists Final Observations OUTLOOK AND RECOMMENDATIONS EPILOGUE REFERENCES APPENDICES
